Nanotechnology Now

Our NanoNews Digest Sponsors

Home > News > Interim Report Obducat

April 29th, 2004

Interim Report Obducat

Abstract:
Directed new share issue in January 2004 contributed some SEK 13 million, Turnover SEK 4,4 (9,0) million - forecast sales growth of 25-30 per cent in 2004 remains, Obducat partner in EU sponsored nano project NaPa, Pre-tax profit was SEK –9,5 million (–7,9) and earnings per share before deferred dilution was SEK –0,05 (-0,05). (PDF)

Source:
Obducat

Bookmark:

Related News Press

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

	The latest news from around the world, FREE

Premium Products
	Only the news you want to read!  Learn More
	Full-service, expert consulting  Learn More

Nanotechnology Now Featured Books

© Copyright 1999-2023 7th Wave, Inc. All Rights Reserved

PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE